| Empagliflozin ameliorates adverse left ventricular remodeling in nondiabetic heart failure by enhancing myocardial energetics CG Santos-Gallego, JA Requena-Ibanez, R San Antonio, K Ishikawa, ... Journal of the American College of Cardiology 73 (15), 1931-1944, 2019 | 537 | 2019 |
| Empagliflozin ameliorates diastolic dysfunction and left ventricular fibrosis/stiffness in nondiabetic heart failure: a multimodality study CG Santos-Gallego, JA Requena-Ibanez, R San Antonio, ... Cardiovascular Imaging 14 (2), 393-407, 2021 | 156 | 2021 |
| Predictors of device-related thrombus following percutaneous left atrial appendage occlusion T Simard, RG Jung, K Lehenbauer, K Piayda, R Pracoń, GG Jackson, ... Journal of the American College of Cardiology 78 (4), 297-313, 2021 | 149 | 2021 |
| Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-registry A Sedaghat, V Vij, B Al-Kassou, S Gloekler, R Galea, M Fürholz, B Meier, ... Circulation: Cardiovascular Interventions 14 (5), e010195, 2021 | 65 | 2021 |
| Do the SGLT-2 inhibitors offer more than hypoglycemic activity? E Flores, CG Santos-Gallego, N Diaz-Mejía, JJ Badimon Cardiovascular drugs and therapy 32, 213-222, 2018 | 48 | 2018 |
| Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia G Jiménez-Brítez, X Freixa, E Flores-Umanzor, R San Antonio, G Caixal, ... Resuscitation 114, 141-145, 2017 | 40 | 2017 |
| Pulmonary ridge coverage and device-related thrombosis after left atrial appendage occlusion: Pulmonary ridge coverage after LAA occlusion X Freixa, P Cepas-Guillen, E Flores-Umanzor, A Regueiro, L Sanchis, ... EuroIntervention 16 (15), e1288, 2021 | 28 | 2021 |
| Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction G Caldentey, P García De Frutos, H Cristóbal, M Garabito, A Berruezo, ... European Heart Journal: Acute Cardiovascular Care 8 (8), 708-716, 2019 | 25 | 2019 |
| Low dose of direct oral anticoagulants after left atrial appendage occlusion PL Cepas-Guillen, E Flores-Umanzor, A Regueiro, S Brugaletta, C Ibanez, ... Journal of Cardiovascular Development and Disease 8 (11), 142, 2021 | 22 | 2021 |
| Percutaneous left atrial appendage closure, a safe alternative to anticoagulation for patients with nonvalvular atrial fibrillation and end‐stage renal disease on hemodialysis … M Xipell, E Flores‐Umanzor, R Ojeda, M Arias, PL Cepas‐Guillén, ... Artificial Organs 44 (5), 513-521, 2020 | 22 | 2020 |
| Impact of revascularization versus medical therapy alone for chronic total occlusion management in older patients EJ Flores‐Umanzor, S Vázquez, P Cepas‐Guillen, J Ivey‐Miranda, ... Catheterization and Cardiovascular Interventions 94 (4), 527-535, 2019 | 21 | 2019 |
| Antithrombotic management after left atrial appendage closure: current evidence and future perspectives J Mesnier, P Cepas-Guillén, X Freixa, E Flores-Umanzor, K Hoang Trinh, ... Circulation: Cardiovascular Interventions 16 (5), e012812, 2023 | 18 | 2023 |
| Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry V Vij, K Piayda, D Nelles, S Gloekler, R Galea, M Fürholz, B Meier, ... Clinical Research in Cardiology 111 (11), 1276-1285, 2022 | 17 | 2022 |
| Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification E Fernández-Peregrina, I Pascual, X Freixa, G Tirado-Conte, ... EuroIntervention 17 (16), 1300, 2022 | 17 | 2022 |
| Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome G Jiménez-Brítez, X Freixa, E Flores, D Penela, M Hernandez-Enríquez, ... Resuscitation 106, 108-112, 2016 | 17 | 2016 |
| Outcomes of nonagenarians with ST elevation myocardial infarction PL Cepas-Guillén, J Borrego-Rodriguez, E Flores-Umanzor, ... The American journal of cardiology 125 (1), 11-18, 2020 | 16 | 2020 |
| Cardiac magnetic resonance as an alternative to endomyocardial biopsy to predict recoverability of left ventricular function in methamphetamine-associated cardiomyopathy M Pujol-López, L Ortega-Paz, EJ Flores-Umanzor, RJ Perea, X Bosch JACC: Heart Failure 5 (11), 853-854, 2017 | 15 | 2017 |
| Impact of device implant depth after left atrial appendage occlusion P Cepas-Guillén, E Flores-Umanzor, N Leduc, V Bajoras, N Perrin, ... Cardiovascular Interventions 16 (17), 2139-2149, 2023 | 13 | 2023 |
| Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes EJ Flores‐Umanzor, PL Cepas‐Guillen, S Vázquez, ... Catheterization and Cardiovascular Interventions 97 (3), 376-383, 2021 | 13 | 2021 |
| Paravalvular leakages after surgical aortic-valve replacement and after transcatheter aortic-valve implantation: strategies to increase the success rate of percutaneous closure X Freixa, R Gabani, P Cepas-Guillén, E Flores-Umanzor, ... Journal of Clinical Medicine 11 (11), 2989, 2022 | 12 | 2022 |
